Agilent Technologies, Inc.
Health
Performance
4.6
Risk
Sell
Buy
Curious about the Scores? Learn more.

Agilent Technologies, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

12.01.2026
Momentum tanked. Clearly underperforming.
10.01.2026
Fragile setup. Still failing to meet the key marks today.
26.11.2025
Risk creeping up. Stability not bulletproof anymore.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.

Agilent Technologies, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Agilent Technologies, Inc. do? Business model and key facts

Get the full picture of Agilent Technologies, Inc.: what it builds, where it operates, and how it makes money.

Agilent Technologies, Inc. Profile

Sector: Healthcare

Industry: Medical - Diagnostics & Research

Employees (FY): 17900

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

shop
Company facts
Padraig McDonnell
CEO
17900
Employees worldwide
shop
Performance
1.83%
Last 12 months
14.75%
Last 5 years
shop
Growth
$6,51B
Revenue year
$1,29B
Net income
shop
Valuation
$41,06B
Market Cap
24.21
Price/Earnings Ratio

Stocks related to Agilent Technologies, Inc.

Selected based on industry alignment and relative market positioning.

IQV
IQVIA Holdings Inc.
241.28
-0.03%
4.6
Sell
Buy
IQVIA Holdings Inc.
IDXX
IDEXX Laboratories, Inc.
712.12
+0.23%
4.9
Sell
Buy
IDEXX Laboratories, Inc.
DHR
Low-poly 3D Danaher (DHR) stock icon with a stylized microscope, symbolizing healthcare and biotech.
239.89
+0.82%
4.0
Sell
Buy
Danaher Corporation
NTRA
Natera, Inc.
240.34
+0.48%
6.7
Sell
Buy
Natera, Inc.
MTD
Mettler-Toledo International Inc.
1,496.61
+0.74%
4.7
Sell
Buy
Mettler-Toledo International Inc.

Agilent Technologies, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.